Latin America Botulinum Toxin Market 2023-2030

Latin America Botulinum Toxin Market 2023-2030

Market Outlook

Triton Market Research’s report suggests that the botulinum toxin market in Latin America is projected to advance with a compound annual growth rate of 10.11% during the forecast period 2023-2030. Brazil, Mexico, and Rest of Latin America are studied in the region’s market.

The incentive to seek medical and cosmetic treatments in Mexico stems from refined aesthetic expertise and cost-effective treatments. A substantial number of individuals from nearby developed nations opt to seek cosmetic treatments in Mexico. Consequently, this trend has led to a gradual rise in the availability of non-surgical procedures within the country over recent years. These factors are anticipated to accelerate the botulinum toxin market’s progression.

Likewise, the number of botulinum toxin procedures has gained significant momentum across Brazil. This growth can be attributed to the healthcare industry’s cost-effective and advanced medical services. Besides this, strategic initiatives by players have fueled the adoption of botulinum toxin. For instance, Daewoong Pharma gained approval for the botulinum toxin Nabota in 2020. Therefore, all these factors are expected to accelerate the studied market’s progression.
Competitive Outlook
The key firms in the botulinum toxin market include Galderma SA, Candela Medical Corporation, Ipsen Pharma, Hugel Inc, and Revance Therapeutics Inc.